- Home
- CRDF vs NCA Comparison
CRDF vs NCA Comparison
Compare CRDF & NCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDF
- NCA
- Stock Information
- Founded
- CRDF 1999
- NCA 1987
- Country
- CRDF United States
- NCA United States
- Employees
- CRDF N/A
- NCA N/A
- Industry
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- NCA Investment Managers
- Sector
- CRDF Health Care
- NCA Finance
- Exchange
- CRDF Nasdaq
- NCA Nasdaq
- Market Cap
- CRDF 196.2M
- NCA N/A
- IPO Year
- CRDF N/A
- NCA N/A
- Fundamental
- Price
- CRDF $2.63
- NCA $8.64
- Analyst Decision
- CRDF Strong Buy
- NCA
- Analyst Count
- CRDF 4
- NCA 0
- Target Price
- CRDF $12.00
- NCA N/A
- AVG Volume (30 Days)
- CRDF 1.1M
- NCA 59.6K
- Earning Date
- CRDF 05-20-2025
- NCA 01-01-0001
- Dividend Yield
- CRDF N/A
- NCA 3.92%
- EPS Growth
- CRDF N/A
- NCA N/A
- EPS
- CRDF N/A
- NCA N/A
- Revenue
- CRDF $683,000.00
- NCA N/A
- Revenue This Year
- CRDF N/A
- NCA N/A
- Revenue Next Year
- CRDF N/A
- NCA N/A
- P/E Ratio
- CRDF N/A
- NCA N/A
- Revenue Growth
- CRDF 39.96
- NCA N/A
- 52 Week Low
- CRDF $2.01
- NCA $7.77
- 52 Week High
- CRDF $5.64
- NCA $9.12
- Technical
- Relative Strength Index (RSI)
- CRDF 41.22
- NCA 62.72
- Support Level
- CRDF $2.42
- NCA $8.42
- Resistance Level
- CRDF $2.87
- NCA $8.58
- Average True Range (ATR)
- CRDF 0.18
- NCA 0.09
- MACD
- CRDF 0.01
- NCA 0.03
- Stochastic Oscillator
- CRDF 24.42
- NCA 100.00
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.